Products for Research Use Only
RegisterLogin

LLS30

CAT: 0804-HY-117404Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-117404Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LLS30 is an anticancer agent. LLS30 suppresses MEK/ERK pathway. LLS30 has anti-cancer effects against ovarian cancer, prostate cancer, and malignant peripheral nerve sheath tumors. LLS30 shows synergistic anti-cancer effect with Enzalutamide or Docetaxel (HY-B0011).
CAS Number
2138367-58-3
UNSPSC
12352005
Target
ERK; MEK
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(N)CC(C1=CC=C2N(CC3=CC=C(Cl)C(Cl)=C3)C(C4=CC=C(N(CCO)CCO)C=C4)=NC2=C1)NCC5=CC=C(Cl)C(Cl)=C5
Molecular Formula
C34H33Cl4N5O3
Molecular Weight
701.47
References & Citations
[1]Kit S. Lam, et al. Lls compounds for treatment of cancer. WO2017176767A1. WIPO (PCT) . 2017-04-04.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
T69874-01LLS30

Popular Products